Journal
Eden Review 2026: The Widest Footprint, an In-House Pharmacy, and Now-Published Prices
Released: Last reviewed:
Short answer — August 2026
Eden owns two superlatives in our database: the widest reported footprint (~fifty states) and the market's clearest vertical integration — Contigo Compounding, the 503A pharmacy Eden acquired in August 2025 and operates in-house. In August 2026 the trade sat on the price axis: tier-based pricing largely revealed at intake. That has changed. On October 15, 2026 Eden's own page printed $129 a month for compounded tirzepatide and $99 a month for semaglutide, flat at every dose, no membership fee. With prices printed, the review now turns on a different question: what the integration adds, and what to confirm in writing before you pay.
What owning the pharmacy actually changes
In-house compounding converts this site's hardest question — which pharmacy, and can you verify it? — into a structural given: the pharmacy is Contigo, the name is public, and the fifteen-minute verification (state licenses including your state's non-resident register, FDA compounding records, accreditation, certificate of analysis) runs against a fixed target rather than an intake-extracted one. It also plausibly delivers what Eden's materials claim: micro-titration flexibility, faster dose adjustments, supply-chain control. The honest counterweight: integration concentrates accountability as well as capability — prescriber, dispenser, and seller under one roof removes the independent-pharmacy check-and-balance the traditional model carries — which is why the COA request matters more here, not less, and why "we test everything" claims should arrive as documents.
The prices and the verdict
Our August 2026 record carried provider-stated figures near $198 for semaglutide and $408 for tirzepatide, revealed at intake, and kept Eden recorded but unranked. Eden's October 15, 2026 page replaces that with printed flat prices: $129 a month for tirzepatide and $99 a month for semaglutide, "No membership fees," and "No dose-based price hikes." For comparison, as of November 6, 2026 our editor's pick NexLife lists $129 a month for tirzepatide and $109 for semaglutide on its monthly plan, so Eden matches it on tirzepatide and is below it on semaglutide. The checks do not change: confirm at checkout that the price shown is the price charged at your maintenance dose, ask which pharmacy fills your prescription (the page we read did not name it), and get the cancellation terms in writing. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same as Zepbound, Mounjaro, Wegovy or Ozempic; LillyDirect's Zepbound remains the approved-product cross-shop, at $299 to $449 a month by dose under its current terms (see the brand-versus-compounded math). Verdict: with prices now published, Eden is a credible low-price option with the widest reported footprint; the remaining work is the pharmacy and terms questions above.
Questions people ask
How much does Eden cost for GLP-1s?
Eden's weight-loss page, read on October 15, 2026, lists compounded tirzepatide at $129 a month and semaglutide at $99 a month, the same price every month and at every dose, with no membership fee. Our earlier August 2026 record carried intake-revealed figures of about $198 and $408; those are out of date. Confirm the price at checkout for your dose.
What is Contigo Compounding?
Eden's in-house 503A pharmacy, acquired in August 2025 — the market's clearest vertical integration. It makes the pharmacy name a structural given (verification runs against a fixed, public target) while concentrating prescriber, dispenser, and seller under one roof — which is why the certificate-of-analysis request matters more here, not less.
Is Eden available in my state?
Almost certainly: its reported footprint of roughly fifty states is the widest we track, which makes Eden the common fallback in states other programs miss. Confirm at intake as always, and confirm in writing that the printed flat price applies at your maintenance dose.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.